HIV Citations List: August, 2016

Literature Citations

1. Combination Antiretroviral Therapy and Indoleamine 2,3-Dioxygenase in HIV Infections: Challenges and New Opportunities. Ahmad, A., V. Mehraj, M.A. Jenabian, S. Samarani, C. Tremblay, and J.P. Routy. AIDS, 2016. 30(11): p. 1839-1841. PMID[27351927].
[PubMed]. HIV_08_2016.

2. Rational Design, Synthesis, anti-HIV-1 RT and Antimicrobial Activity of Novel 3-(6-Methoxy-3,4-dihydroquinolin-1(2h)-yl)-1-(piperazin-1-yl)propan-1-on E Derivatives. Chander, S., P. Wang, P. Ashok, L.M. Yang, Y.T. Zheng, and S. Murugesan. Bioorganic Chemistry, 2016. 67: p. 75-83. ISI[000379684700007].
[WOS]. HIV_08_2016.

3. Design, Synthesis and Biological Evaluation of Polyphenol-alpha-helical Peptide Conjugates as Potent HIV-1 Fusion Inhibitors. Cheng, S.Q., G.D. Liang, X.F. Jiang, C. Wang, and K.L. Liu. Chemical Journal of Chinese Universities, 2016. 37(7): p. 1287-1292. ISI[000380076900011].
[WOS]. HIV_08_2016.

4. Tyrosine-Sulfated V2 Peptides Inhibit HIV-1 Infection via Coreceptor Mimicry. Cimbro, R., F.C. Peterson, Q. Liu, C. Guzzo, P. Zhang, H. Miao, D. Van Ryk, X. Ambroggio, D.E. Hurt, L. De Gioia, B.F. Volkman, M.A. Dolan, and P. Lusso. EBioMedicine, 2016. 10: p. 45-54. PMID[27389109].
[PubMed]. HIV_08_2016.

5. Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors. Corona, A., J. Desantis, S. Massari, S. Distinto, T. Masaoka, S. Sabatini, F. Esposito, G. Manfroni, E. Maccioni, V. Cecchetti, C. Pannecouque, S.F. Le Grice, E. Tramontano, and O. Tabarrini. ChemMedChem, 2016. 11(16): p. 1709-1720. PMID[26990134].
[PubMed]. HIV_08_2016.

6. Discovery and Structure-based Optimization of 2-Ureidothiophene-3-carboxylic acids as Dual Bacterial RNA Polymerase and Viral Reverse Transcriptase Inhibitors. Elgaher, W.A., K.K. Sharma, J. Haupenthal, F. Saladini, M. Pires, E. Real, Y. Mely, and R.W. Hartmann. Journal of Medicinal Chemistry, 2016. 59(15): p. 7212-7222. PMID[27339173].
[PubMed]. HIV_08_2016.

7. Synthesis and Evaluation of Substituted 4-(N-Benzylamino)cinnamate Esters as Potential Anti-cancer Agents and HIV-1 Integrase Inhibitors. Faridoon, A.L. Edkins, M. Isaacs, D. Mnkandhla, H.C. Hoppe, and P.T. Kaye. Bioorganic & Medicinal Chemistry, 2016. 26(15): p. 3810-3812. PMID[27317645].
[PubMed]. HIV_08_2016.

8. The Effect of Root, Shoot and Seed Extracts of the Iranian Thymus L. (Family: Lamiaceae) Species on HIV-1 Replication and CD4 Expression. Farsani, M.S., M. Behbahani, and H.Z. Isfahani. Cell Journal, 2016. 18(2): p. 255-261. PMID[27540531]. PMCID[PMC4988425].
[PubMed]. HIV_08_2016.

9. Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity. Giesler, K.E., J. Marengo, and D.C. Liotta. Journal of Medicinal Chemistry, 2016. 59(15): p. 7097-7110. PMID[27405794].
[PubMed]. HIV_08_2016.

10. Toxicity and in Vitro Activity of HIV-1 Latency-reversing Agents in Primary CNS Cells. Gray, L.R., H. On, E. Roberts, H.K. Lu, M.A. Moso, J.A. Raison, C. Papaioannou, W.J. Cheng, A.M. Ellett, J.C. Jacobson, D.F. Purcell, S.L. Wesselingh, P.R. Gorry, S.R. Lewin, and M.J. Churchill. Journal of Neurovirology, 2016. 22(4): p. 455-463. PMID[26727904].
[PubMed]. HIV_08_2016.

11. The Janus Kinase Inhibitor Ruxolitinib Reduces HIV Replication in Human Macrophages and Ameliorates HIV Encephalitis in a Murine Model. Haile, W.B., C. Gavegnano, S. Tao, Y. Jiang, R.F. Schinazi, and W.R. Tyor. Neurobiology of Disease, 2016. 92(Pt B): p. 137-143. PMID[26851503]. PMCID[PMC4907871].
[PubMed]. HIV_08_2016.

12. A New Neolignan, and the Cytotoxic and anti-HIV-1 Activities of Constituents from the Roots of Dasymaschalon sootepense. Hongthong, S., C. Kuhakarn, T. Jaipetch, P. Piyachaturawat, S. Jariyawat, K. Suksen, J. Limthongkul, N. Nuntasaen, and V. Reutrakul. Natural Product Communications, 2016. 11(6): p. 809-813. PMID[27534123].
[PubMed]. HIV_08_2016.

13. Synthesis and Evaluation of 2-Pyridinylpyrimidines as Inhibitors of HIV-1 Structural Protein Assembly. Kozisek, M., O. Stepanek, K. Parkan, C. Berenguer Albinana, M. Pavova, J. Weber, H.G. Krusslich, J. Konvalinka, and A. Machara. Bioorganic & Medicinal Chemistry, 2016. 26(15): p. 3487-3490. PMID[27353536].
[PubMed]. HIV_08_2016.

14. Extracellular Histones Identified in Crocodile Blood Inhibit in-Vitro HIV-1 Infection. Kozlowski, H.N., E.T. Lai, P.C. Havugimana, C. White, A. Emili, D. Sakac, B. Binnington, A. Neschadim, S.D. McCarthy, and D.R. Branch. AIDS, 2016. 30(13): p. 2043-2052. PMID[27191975].
[PubMed]. HIV_08_2016.

15. Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs via a Structure-based Bioisosterism Approach. Li, X., B. Huang, Z. Zhou, P. Gao, C. Pannecouque, D. Daelemans, E. De Clercq, P. Zhan, and X. Liu. Chemical Biology & Drug Design, 2016. 88(2): p. 241-253. PMID[26914186].
[PubMed]. HIV_08_2016.

16. An Effective Conjugation Strategy for Designing Short Peptide-based HIV-1 Fusion Inhibitors. Liang, G., H. Wang, H. Chong, S. Cheng, X. Jiang, Y. He, C. Wang, and K. Liu. Organic & Biomolecular Chemistry, 2016. 14(33): p. 7875-7882. PMID[27454320].
[PubMed]. HIV_08_2016.

17. Gallic acid is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection. LoRicco, J.G., C.S. Xu, J. Neidleman, M. Bergkvist, W.C. Greene, N.R. Roan, and G.I. Makhatadze. Journal of Biological Chemistry, 2016. 291(27): p. 14045-14055. PMID[27226574]. PMCID[PMC4933164].
[PubMed]. HIV_08_2016.

18. Discovery and Characterization of Novel Small-molecule CXCR4 Receptor Agonists and Antagonists. Mishra, R.K., A.K. Shum, L.C. Platanias, R.J. Miller, and G.E. Schiltz. Scientific Reports, 2016. 6(30155): 9pp. PMID[27456816]. PMCID[PMC4960487].
[PubMed]. HIV_08_2016.

19. 1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists. Mohammed, I., I.R. Kummetha, G. Singh, N. Sharova, G. Lichinchi, J. Dang, M. Stevenson, and T.M. Rana. Journal of Medicinal Chemistry, 2016. 59(16): p. 7677-7682. PMID[27509004].
[PubMed]. HIV_08_2016.

20. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396. Murgatroyd, C., L. Pirrie, F. Tran, T.K. Smith, N.J. Westwood, and C.S. Adamson. Journal of Virology, 2016. 90(18): p. 8181-8197. PMID[27384665].
[PubMed]. HIV_08_2016.

21. Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function. Pace, M., J. Williams, A. Kurioka, A.B. Gerry, B. Jakobsen, P. Klenerman, N. Nwokolo, J. Fox, S. Fidler, and J. Frater. Plos Pathogens, 2016. 12(8): p. e1005782. PMID[27529554]. PMCID[PMC4986965].
[PubMed]. HIV_08_2016.

22. Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities. Pala, N., F. Esposito, D. Rogolino, M. Carcelli, V. Sanna, M. Palomba, L. Naesens, A. Corona, N. Grandi, E. Tramontano, and M. Sechi. International Journal of Molecular Sciences, 2016. 17(8): 1371. PMID[27556447]. PMCID[PMC5000766].
[PubMed]. HIV_08_2016.

23. Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-dependent Manner by Modulating Viral Attachment. Parker, Z.F., A.H. Rux, A.M. Riblett, F.H. Lee, L. Rauova, D.B. Cines, M. Poncz, B.S. Sachais, and R.W. Doms. AIDS Research and Human Retroviruses, 2016. 32(7): p. 705-717. ISI[000379609100013].
[WOS]. HIV_08_2016.

24.Application of the Huisgen Cycloaddition and 'Click' Reaction Toward Various 1,2,3-Triazoles as HIV Non-Nucleoside Reverse Transcriptase Inhibitors. Pribut, N., C.G. Veale, A.E. Basson, W.A. van Otterlo, and S.C. Pelly. Bioorganic & Medicinal Chemistry Letters, 2016. 26(15): p. 3700-3704. PMID[27287366].
[PubMed]. HIV_08_2016.

25. Isolation and Characterization of a Novel Neutralizing Antibody Targeting the CD4-binding Site of HIV-1 gp120. Qiao, Y., L. Man, Z. Qiu, L. Yang, Y. Sun, and Y. He. Antiviral Research, 2016. 132: p. 252-261. PMID[27387828].
[PubMed]. HIV_08_2016.

26. Synthesis and anti-HIV Activity of 5'-Homo-2',3'-dideoxy-2',3'-didehydro-4'-selenonucleosides (5'-Homo-4'-Se-d4Ns). Qu, S., G. Kim, J. Yu, P.K. Sahu, Y. Choi, S.D. Naik, and L.S. Jeong. Asian Journal of Organic Chemistry, 2016. 5(6): p. 735-741. ISI[000380260200004].
[WOS]. HIV_08_2016.

27. Anti-nuclear Antibodies in Autoimmune Prone Mice Are Protective against HIV. Schroeder, K.M., P. Strauch, M. Harper, R. Pelanda, M.L. Santiago, and R.M. Torres. Journal of Immunology, 2016. 196(1 Sup.): 47.3. ISI[000380288300252].
[WOS]. HIV_08_2016.

28. Discovery, Characterization, and Lead Optimization of 7-Azaindole Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Stanton, R.A., X. Lu, M. Detorio, C. Montero, E.T. Hammond, M. Ehteshami, R.A. Domaoal, J.H. Nettles, M. Feraud, and R.F. Schinazi. Bioorganic & Medicinal Chemistry Letters, 2016. 26(16): p. 4101-4105. PMID[27390064].
[PubMed]. HIV_08_2016.

29. G-quadruplexes with Tetra(ethylene glycol)-modified deoxythymidines Are Resistant to Nucleases and Inhibit HIV-1 Reverse Transcriptase. Tateishi-Karimata, H., T. Muraoka, K. Kinbara, and N. Sugimoto. ChemBioChem, 2016. 17(15): p. 1399-1402. PMID[27251574].
[PubMed]. HIV_08_2016.

30. Rice Endosperm Is Cost-effective for the Production of Recombinant Griffithsin with Potent Activity against HIV. Vamvaka, E., E. Arcalis, K. Ramessar, A. Evans, B.R. O'Keefe, R.J. Shattock, V. Medina, E. Stoger, P. Christou, and T. Capell. Plant Biotechnology Journal, 2016. 14(6): p. 1427-1437. PMID[26800650]. PMCID[PMC4865440].
[PubMed]. HIV_08_2016.

31. Anti-alpha(4)beta(7) mAb Prevents MAdCAM-1-mediated Activation and HIV Replication in CD4(+) T Cells. Waliszewski, M., F. Nawaz, C. Cicala, J. Ray, R. Olowojesiku, I. Perrone, D.L. Wei, K. Jelicic, D. van Ryk, A.A. Ansari, A.S. Fauci, and J. Arthos. Journal of Immunology, 2016. 196(1 Sup.): 208.15. ISI[000380288301214].
[WOS]. HIV_08_2016.

32. Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase. Wang, W.Y., J.H. Wong, D.T. Ip, D.C. Wan, R.C. Cheung, and T.B. Ng. Applied Biochemistry and Biotechnology, 2016. 179(7): p. 1202-1212. PMID[27022750].
[PubMed]. HIV_08_2016.

33. Effect of Intercalator and Lewis Acid-base Branched Peptide Complex Formation: Boosting Affinity Towards HIV-1 RRE RNA. Wynn, J.E., W.Y. Zhang, D.M. Tebit, L.R. Gray, M.L. Hammarskjold, D. Rekosh, and W.L. Santos. MedChemComm, 2016. 7(7): p. 1436-1440. PMID[27453773]. PMCID[PMC4957400].
[PubMed]. HIV_08_2016.

34. Characterization and in Vitro Activity of a Branched Peptide Boronic acid That Interacts with HIV-1 RRE RNA. Wynn, J.E., W.Y. Zhang, D.M. Tebit, L.R. Gray, M.L. Hammarskjold, D. Rekosh, and W.L. Santos. Bioorganic & Medicinal Chemistry, 2016. 24(17): p. 3947-3952. PMID[27091070]. PMCID[PMC4972714].
[PubMed]. HIV_08_2016.

35. Methylene bisphosphonates as the Inhibitors of HIV RT Phosphorolytic Activity. Yanvarev, D.V., A.N. Korovina, N.N. Usanov, O.A. Khomich, J. Vepsalainen, E. Puljula, M.K. Kukhanova, and S.N. Kochetkov. Biochimie, 2016. 127: p. 153-162. PMID[27230835].
[PubMed]. HIV_08_2016.

36. Alpha-1-antitrypsin Interacts with gp41 to Block HIV-1 Entry into CD4+T Lymphocytes. Zhou, X.Y., Z. Liu, J. Zhang, J.W. Adelsberger, J. Yang, and G.F. Burton. BMC Microbiology, 2016. 16(1): 172. PMID[27473095]. PMCID[PMC4966588].
[PubMed]. HIV_08_2016.

Patent Citations

37. Preparation of Triazole and Tetrazole Inhibitors of Human DDX3 Helicase as Antiviral Therapeutic Agents. Meyerhans, A., M.-A. Martinez de la Sierra, A. Brai, R. Fazi, C. Tintori, M. Botta, J.-E. Araque, and J. Martinez. Patent. 2016. 2016-EP52990 2016128541: 174pp.

[Patent]. HIV_08_2016.

38. Griffithsin Mutants. O'Keefe, B.R., T. Moulaei, K.E. Palmer, L.C. Rohan, and J.L. Fuqua. Patent. 2016. 2016-US17267 2016130628: 32pp.

[Patent]. HIV_08_2016.

39. Quinoline Derivatives for Use in the Treatment or Prevention of Viral Infection, in Particular HIV Infection. Scherrer, D., A. Garcel, N. Campos, J. Tazi, A. Vautrin, F. Mahuteau-Betzer, R. Najman, and P. Fornarelli. Patent. 2016. 2015-305277 3058940: 39pp.

[Patent]. HIV_08_2016.

40. Compositions and Methods for Inhibiting Viral Infection by Administering AR-12 and Its Analogs. Schlesinger, L., J. Yount, A. Zukiwski, S. Proniuk, M.J. Tunon, and K. Zandi. Patent. 2016. 2016-15008306 20160213647: 43pp.

[Patent]. HIV_08_2016.

41. Small Molecules Targeting HIV-1 Nef. Smithgall, T.E. Patent. 2016. 2016-15042069 20160235750: 16pp.

[Patent]. HIV_08_2016.